Annual ROE
-68.22%
-35.43%-108.05%
December 31, 2023
Summary
- As of February 7, 2025, KTTA annual return on equity is -68.22%, with the most recent change of -35.43% (-108.05%) on December 31, 2023.
- KTTA annual ROE is now -711.18% below its all-time high of -8.41%, reached on December 31, 2021.
Performance
KTTA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-81.66%
-7.03%-9.42%
September 30, 2024
Summary
- As of February 7, 2025, KTTA quarterly return on equity is -81.66%, with the most recent change of -7.03% (-9.42%) on September 30, 2024.
- Over the past year, KTTA quarterly ROE has dropped by -7.03% (-9.42%).
- KTTA quarterly ROE is now -655.41% below its all-time high of -10.81%, reached on March 31, 2022.
Performance
KTTA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KTTA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -108.0% | -9.4% |
| 3 y3 years | - | -331.1% |
| 5 y5 years | - | -331.1% |
KTTA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -711.2% | at low | -655.4% | at low |
| 5 y | 5-year | -711.2% | at low | -655.4% | +56.7% |
| alltime | all time | -711.2% | at low | -655.4% | +56.7% |
Pasithea Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -81.66%(+9.4%) |
| Jun 2024 | - | -74.63%(+22.9%) |
| Mar 2024 | - | -60.74%(+20.3%) |
| Dec 2023 | -68.22%(+108.1%) | -50.47%(+14.6%) |
| Sep 2023 | - | -44.04%(+6.2%) |
| Jun 2023 | - | -41.47%(+17.3%) |
| Mar 2023 | - | -35.35%(+22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -32.79%(+289.9%) | -28.78%(+52.0%) |
| Sep 2022 | - | -18.94%(+56.4%) |
| Jun 2022 | - | -12.11%(+12.0%) |
| Mar 2022 | - | -10.81%(-13.9%) |
| Dec 2021 | -8.41% | -12.55%(-73.4%) |
| Sep 2021 | - | -47.13%(-75.0%) |
| Jun 2021 | - | -188.43%(+201.2%) |
| Mar 2021 | - | -62.57% |
FAQ
- What is Pasithea Therapeutics annual return on equity?
- What is the all time high annual ROE for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual ROE year-on-year change?
- What is Pasithea Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly ROE year-on-year change?
What is Pasithea Therapeutics annual return on equity?
The current annual ROE of KTTA is -68.22%
What is the all time high annual ROE for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual return on equity is -8.41%
What is Pasithea Therapeutics annual ROE year-on-year change?
Over the past year, KTTA annual return on equity has changed by -35.43% (-108.05%)
What is Pasithea Therapeutics quarterly return on equity?
The current quarterly ROE of KTTA is -81.66%
What is the all time high quarterly ROE for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly return on equity is -10.81%
What is Pasithea Therapeutics quarterly ROE year-on-year change?
Over the past year, KTTA quarterly return on equity has changed by -7.03% (-9.42%)